Autoimmune disorders of erythropoiesis

Current Opinion in Hematology

Volumn 8, Issue 2, 2001, Pages 68-73

  Croisille, Laure ^a   Tchernia, Gil ^a   Casadevall, Nicole ^b  

^a BICÊTRE HOSPITAL   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ERYTHROPOIETIN; FAS ANTIBODY; IMMUNOGLOBULIN;

ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; DISEASE SEVERITY; DYSERYTHROPOIESIS; ERYTHROCYTE APLASIA; ERYTHROID CELL; HUMAN; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RETICULOCYTE COUNT; SYNDROME; THYMOMA;

ANIMALS; ANTIGENS, CD95; AUTOANTIBODIES; AUTOIMMUNE DISEASES; ERYTHROPOIESIS; HUMANS; RED-CELL APLASIA, PURE;

EID: 0035092646     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200103000-00002     Document Type: Article

References (48)

1. The biology of pure cell aplasia
2. Acquired bone marrow failure
3. Acquired pure red cell aplasia
4. Erythroblastic synartesis: An autoimmune dyserythropoiesis
5. Dyserythropoiesis associated with a Fas-deficient condition in childhood
6. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia
7. Pure red cell aplasia in patients with chronic lymphocytic leukemia
8. Pure red cell aplasia: Association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities
9. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibition receptors
10. Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes
11. Demonstration of two distinct antibodies in autoimmune hemolytic anemia with reticulocytopenia and red cell aplasia
12. Pure red cell aplasia following autoimmune haemolytic anaemia. Cell-mediated suppression of erythropoiesis as a possible pathogenesis of pure red cell aplasia
13. Therapy of pure red cell aplasia
14. Reproducible erythroid aplasia caused by mycophenolate mofetil
15. Temporary pure red-cell aplasia during valproate monotherapy: Clinical observations and spectral electroencephalographic aspects
16. Erythroid progenitors in adult chronic pure red cell aplasia: Relationship of in vitro erythroid colonies to therapeutic response
17. The pathophysiology of pure red cell aplasia: Implications for therapy
18. Successful treatment with cyclosporine A of pure red-cell aplasia occurring 11 years after thymectomy
19. Inhibition of erythropoiesis by a factor present in the plasma of patients with erythroblastopenia
20. Pure red cell aplasia and thymona: Loss of serum inhibitor of erythropoiesis following thymectomy
21. Auroreactive erythroid progenitor-T suppressor cells in the pure red cell aplasia associated with thymona and panhypoglobulinemia
22. Pure red cell aplasia. Lymphocyte inhibition of erythropoiesis
23. T cell chronic lymphocytic leukemia: Presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro
24. Pure red cell aplasia and hypogammaglobulinemia associated with Tr cell chronic lymphocytic leukemia
25. Human T cell leukemia virus-T-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease
26. Evidence for genetic restriction in the suppression of erythropïesis by a unique subset of T-lymphocytes in man
27. T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia
28. Pure red cell aplasia in a patient with chronic granulocytic leukaemia treated with interferon-α
29. Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with anti-erythropoietin-like activity
30. Pure red cell aplasia: Studies on an IgG serum inhibitor neutralizing erythopoietin
31. Pure red cell aplasia as presentation of systemic lupus erythematosus: Antibodies to erythropoietin
32. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: Correlation with anemia
33. Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia
34. Transient erythroblastopenia of childhood: Varied pathogenesis
35. Transient erythroblastopenia of childhood. Evidence for cell-mediated suppression of erythropoiesis
36. Case of transient erythroblastopenia of childhood with transient hypogammaglobulinemia
37. Septate-like junctions acquired by erythroblasts in a case of refractory anemia
38. Ultrastructure of mutual adhesion and multinuclearity of erythroblasts in patients with dyserythropoietic anemia
39. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene in lpr mice
40. Generalized lymphoproloferative disease in mice, caused by a point mutation in the Fas-ligand
41. Mutations in Fas associated with human lymphoproloferative syndrome and auto immunity
42. Clinical, immunological, and pathological consequences of Fas-deficient conditions
43. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis
44. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II
45. Deficiency of the Fas apoptotic pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation
46. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia
47. Une observation de rémission post padum d'une dysérythropoïèse acquise, une cause rare d'anémie au cours du lupus érythémateux disséminé
48. Apoptotic role of Fas/Fas-ligand system in the regulation of erythropoiesis